Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

View the 50 largest pharmaceutical companies in the world listings here

Bayer in the Drug Discovery & Development Pharma 50

Bayer (Pharmaceuticals Division)

Rank: 16

2022 Rank: 20

Berlin (Pharmaceuticals Division HQ), Germany
www.bayer.com/en/pharmaceuticals/pharmaceuticals-division

2022 Revenues ($USD) : $20,280,056,800.00
2022 Revenues (foreign currencies) : €19,252,000,000
2022 R&D spend : $3,578,399,800.00
2022 Number of Employees : 101,369 (companywide)
Fiscal Year End : 12/31/22
Leader : CEO Bill Anderson (effective June 2023)

Bayer's pharmaceutical division reported strong revenues of €19.3 billion in 2022, with Xarelto, a blood clot-reducing medication, standing out as its top drug, generating roughly €4.5 billion. The company plans to significantly boost its investment in U.S.-based pharmaceutical R&D by earmarking €1 billion (approximately $1 billion) for 2023, aiming to double sales in the country by the end of the decade. Bayer's pharma division concentrates on prescription products, especially for cardiology and women's healthcare. It has a focus on specialty therapeutics in oncology, hematology and ophthalmology. —BB
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Views
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE